Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julian Adams currently holds 4,100 shares of Elicio Therapeutics, Inc. (ELTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julian Adams has been a net neutral trader of ELTX stock. They have purchased $0 and sold $0 worth of shares.
Julian Adams's most recent insider trade was on Nov 21, 2024, when they sold 4,100 shares at $0.00 per share.
Julian Adams serves as Executive at Elicio Therapeutics, Inc. (ELTX). They have executed 13 insider transactions totaling $0 over their tenure at the company.
Julian Adams holds the position of Executive at Elicio Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Julian Adams has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Julian Adams was on Oct 28, 2008, when they sold $111.6K worth of INFI shares. This transaction involved 54,727 shares at $2.04 per share.
Julian Adams currently owns 4,100 shares of Elicio Therapeutics, Inc. (ELTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julian Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julian Adams has 13 Form 4 filings on record as an insider at Elicio Therapeutics, Inc..
Set alerts for Julian Adams and 40,000+ other insiders.